Recurrent Adult Soft Tissue Sarcoma Completed Phase 2 Trials for Selumetinib (DB11689)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028931 (Recurrent Adult Soft Tissue Sarcoma) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01206140 | Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery | Treatment |